EUVIMEDEUVIMED entdecken
Crossref

Development of a quantitative LC–MS/MS method for assessment of xylazine in urine

Rejwi Acharya Dahal, Elizabeth Crosby, Jennifer Beckman

Analytical Biochemistry · 2026-09 · 716 · 116158

DOI: 10.1016/j.ab.2026.116158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Biochemistry, 2026-09. Verfasst von Rejwi Acharya Dahal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Division of Clinical Chemistry, Indian…. Hauptthemen laut MEDLINE: Liquid Chromatography-Mass Spectrometry, Tandem Mass Spectrometry, Xylazine. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xylazine, an alpha 2 adrenergic agonist approved for veterinary use, has become an increasingly common adulterant in the illicit drug supply and is frequently detected with fentanyl and other substances, exacerbating opioid epidemic. Because xylazine is not included in many routine toxicology screens, a practical quantitative urine method is needed for clinical testing and surveillance. We developed and validated a quantitative dilute and shoot method for xylazine in urine using liquid chromatography-tandem mass spectrometry (LC-MS/MS) with water (containing 0.1% formic acid) and methanol (containing 0.1% formic acid) as the aqueous and organic mobile phase, respectively. The assay was linear from 20 to 5000 μg/L, with administratively set limit of quantitation (LOQ) of 20 μg/L and cutoff of 40 μg/L. In 94 authentic urine samples, 11 were above the LOQ (two of which were below the cutoff), with a maximum concentration of 4298 μg/L. The validated method provides robust quantitative measurement of xylazine in urine across clinically relevant concentrations and is well suited for high throughput clinical toxicology and surveillance testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liquid Chromatography-Mass SpectrometryTandem Mass SpectrometryXylazineHumansLimit of DetectionReproducibility of Results

Substanzen

Xylazine

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Division of Clinical Chemistry, Indiana University Health Pathology Laboratory, Indianapolis, IN, USA; India…
  • Division of Clinical Chemistry, Indiana University Health Pathology Laboratory, Indianapolis, IN, USA.
  • Indiana University School of Medicine, Indianapolis, IN, USA.

Zitieren

APA

Dahal, R. A., Crosby, E., & Beckman, J. (2026). Development of a quantitative LC–MS/MS method for assessment of xylazine in urine. Analytical Biochemistry, 716, 116158. https://doi.org/10.1016/j.ab.2026.116158

Vancouver

Dahal RA, Crosby E, Beckman J. Development of a quantitative LC–MS/MS method for assessment of xylazine in urine. Analytical Biochemistry. 2026;716:116158. doi:10.1016/j.ab.2026.116158

BibTeX
@article{Dahal2026,
  author = {Dahal, Rejwi Acharya and Crosby, Elizabeth and Beckman, Jennifer},
  title = {Development of a quantitative LC–MS/MS method for assessment of xylazine in urine},
  journal = {Analytical Biochemistry},
  year = {2026},
  volume = {716},
  pages = {116158},
  doi = {10.1016/j.ab.2026.116158}
}
Kostenlos starten →